DK1257564T3 - Fremgangsmåde til oprensning af rekombinant HCG med en specifik bioaktivitet - Google Patents

Fremgangsmåde til oprensning af rekombinant HCG med en specifik bioaktivitet

Info

Publication number
DK1257564T3
DK1257564T3 DK01901188T DK01901188T DK1257564T3 DK 1257564 T3 DK1257564 T3 DK 1257564T3 DK 01901188 T DK01901188 T DK 01901188T DK 01901188 T DK01901188 T DK 01901188T DK 1257564 T3 DK1257564 T3 DK 1257564T3
Authority
DK
Denmark
Prior art keywords
hcg
specific bioactivity
purification
ion
recombinant hcg
Prior art date
Application number
DK01901188T
Other languages
Danish (da)
English (en)
Inventor
Gianfranco Paradisi
Mara Rossi
Laura Scaglia
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of DK1257564T3 publication Critical patent/DK1257564T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DK01901188T 2000-02-22 2001-01-22 Fremgangsmåde til oprensning af rekombinant HCG med en specifik bioaktivitet DK1257564T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
PCT/EP2001/000665 WO2001062773A1 (en) 2000-02-22 2001-01-22 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD

Publications (1)

Publication Number Publication Date
DK1257564T3 true DK1257564T3 (da) 2008-10-06

Family

ID=8167925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01901188T DK1257564T3 (da) 2000-02-22 2001-01-22 Fremgangsmåde til oprensning af rekombinant HCG med en specifik bioaktivitet

Country Status (32)

Country Link
US (2) US7297777B2 (zh)
EP (2) EP1752466A3 (zh)
JP (1) JP4588960B2 (zh)
KR (1) KR100806911B1 (zh)
CN (1) CN100482679C (zh)
AT (1) ATE406378T1 (zh)
AU (2) AU783320B2 (zh)
BG (1) BG65807B1 (zh)
BR (1) BRPI0108556B8 (zh)
CA (1) CA2399020A1 (zh)
CY (1) CY1108460T1 (zh)
CZ (1) CZ303144B6 (zh)
DE (1) DE60135541D1 (zh)
DK (1) DK1257564T3 (zh)
EA (1) EA006605B1 (zh)
EE (1) EE05644B1 (zh)
ES (1) ES2307585T3 (zh)
HK (1) HK1052016A1 (zh)
HR (1) HRP20020650B1 (zh)
HU (2) HU228935B1 (zh)
IL (2) IL151308A0 (zh)
ME (1) ME00296B (zh)
MX (1) MXPA02007871A (zh)
NO (1) NO328694B1 (zh)
PL (1) PL205149B1 (zh)
PT (1) PT1257564E (zh)
RS (1) RS50741B (zh)
SI (1) SI1257564T1 (zh)
SK (1) SK287146B6 (zh)
UA (2) UA86938C2 (zh)
WO (1) WO2001062773A1 (zh)
ZA (1) ZA200206109B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399020A1 (en) * 2000-02-22 2001-08-30 Applied Research Systems Ars Holding N.V. Process of purification of hcg and recombinant hcg purified by that method
EP2163558A3 (en) * 2004-10-04 2010-10-27 Novetide, Ltd. A Counterion Exchange Process for Peptides
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
WO2008007993A1 (fr) * 2006-07-11 2008-01-17 Koval, Anton Alexandrovich Utilisation d'une hormone chorionique ou lutéinisante destinée à la prévention ou au traitement de l'hypogonadisme lié à l'âge
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜促性腺激素的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
WO2012131306A1 (en) 2011-03-31 2012-10-04 Ferring B.V. Pharmaceutical preparation
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜促性腺激素的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0461200T3 (da) * 1989-02-21 1997-03-10 Univ Washington Modificerede former af reproduktionshormoner
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
EP0814841B1 (en) 1995-03-21 2001-12-05 Applied Research Systems ARS Holding N.V. Hcg liquid formulations
UA52646C2 (uk) * 1996-02-20 2003-01-15 Еплайд Рісьорч Системз Ерс Холдінг Н.В. Гібридні білки, фармацевтична композиція, що містить гібридний білок, ізольована молекула днк, що містить гібридний білок, вектор експресії, клітина-хазяїн, спосіб продукування гібридного білка, спосіб індукування визрівання фолікулів
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
AU8142198A (en) 1997-06-12 1998-12-30 Regents Of The University Of California, The A transcription factor coactivator protein, p/cip
DK0998486T4 (da) * 1997-06-13 2012-05-14 Genentech Inc Proteinoprensning ved kromatografi efterfulgt af filtrering på en ladet fase
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
CA2399020A1 (en) * 2000-02-22 2001-08-30 Applied Research Systems Ars Holding N.V. Process of purification of hcg and recombinant hcg purified by that method

Also Published As

Publication number Publication date
BG107000A (en) 2003-04-30
US20070299001A1 (en) 2007-12-27
SK12062002A3 (sk) 2002-12-03
JP4588960B2 (ja) 2010-12-01
PT1257564E (pt) 2008-09-10
ME00296B (me) 2011-05-10
EP1752466A3 (en) 2012-10-10
MXPA02007871A (es) 2003-02-10
BR0108556A (pt) 2003-01-28
KR100806911B1 (ko) 2008-02-22
BG65807B1 (bg) 2009-12-31
HU228935B1 (en) 2013-06-28
RS50741B (sr) 2010-08-31
UA86938C2 (uk) 2009-06-10
IL151308A0 (en) 2003-04-10
US7297777B2 (en) 2007-11-20
EP1257564A1 (en) 2002-11-20
ATE406378T1 (de) 2008-09-15
CN1404485A (zh) 2003-03-19
CY1108460T1 (el) 2014-04-09
SI1257564T1 (sl) 2008-12-31
EP1257564B1 (en) 2008-08-27
NO20023985L (no) 2002-08-21
PL205149B1 (pl) 2010-03-31
AU2006200059A1 (en) 2006-02-02
WO2001062773A1 (en) 2001-08-30
HRP20020650B1 (en) 2011-02-28
NO328694B1 (no) 2010-04-26
AU783320B2 (en) 2005-10-13
HUP0204231A2 (hu) 2003-03-28
HRP20020650A2 (en) 2004-12-31
IL151308A (en) 2009-11-18
EE200200469A (et) 2004-04-15
KR20030001359A (ko) 2003-01-06
CZ303144B6 (cs) 2012-05-02
ES2307585T3 (es) 2008-12-01
SK287146B6 (sk) 2010-01-07
CN100482679C (zh) 2009-04-29
EE05644B1 (et) 2013-04-15
NO20023985D0 (no) 2002-08-21
BRPI0108556B8 (pt) 2021-05-25
EA200200892A1 (ru) 2003-02-27
BRPI0108556B1 (pt) 2015-04-14
HUP0204231A3 (en) 2005-09-28
EP1752466A2 (en) 2007-02-14
UA78488C2 (en) 2007-04-10
EA006605B1 (ru) 2006-02-24
PL357508A1 (en) 2004-07-26
YU60202A (sh) 2005-09-19
US20030104553A1 (en) 2003-06-05
HU1300063D0 (hu) 2003-03-28
AU2680401A (en) 2001-09-03
CA2399020A1 (en) 2001-08-30
DE60135541D1 (de) 2008-10-09
JP2003524015A (ja) 2003-08-12
HK1052016A1 (en) 2003-08-29
ZA200206109B (en) 2003-07-31
MEP38908A (en) 2011-02-10
CZ20022855A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
DK1257564T3 (da) Fremgangsmåde til oprensning af rekombinant HCG med en specifik bioaktivitet
NO20023963D0 (no) Renset LH
PT906122E (pt) Ligantes activados e metodos para os produzir e purificar
WO2002018443A3 (en) A recombinant monoclonal antibody to phosphotyrosine-containing proteins
PT98048A (pt) Metodo de tratamento de celulas cancerosas da bexiga utilizando proteinas hibridas, nomeadamente pe40 modificado ligado a tgf-alfa
BR9301641A (pt) Processo para produzir uma preparacao de fator viii,altamente purificada e uso
DE60034117D1 (de) Verfahren zur herstelllung von gonadotropin-zusammensetzungen
PT1664086E (pt) Separação cromatográfica de polipéptidos terapêuticos
ITPN930033A0 (it) Meccanismo per la trasformazione del moto lineare in rotatorio e viceversa